Castle Rock Wealth Management, LLC Palatin Technologies Inc Transaction History

Castle Rock Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	BUY	$0.34 - $0.86 $1,360 - $3,440	4,000 Added 33.33%	16,000 $6,000
Q3 2021 Nov 12, 2021	BUY	$0.44 - $0.63 $5,280 - $7,560	12,000 New	12,000 $5,000
Q4 2020 Jan 29, 2021	SELL	$0.38 - $0.78 $38,200 - $78,411	-100,528 Closed	0 $0
Q3 2020 Dec 07, 2020	BUY	$0.47 - $0.64 $37,848 - $51,537	80,528 Added 402.64%	100,528 $42,000
Q3 2019 Nov 13, 2019	SELL	$0.78 - $1.09 $62,811 - $87,775	-80,528 Reduced 80.11%	20,000 $16,000
Q2 2019 Aug 08, 2019	BUY	$0.98 - $1.64 $75,920 - $127,050	77,470 Added 335.98%	100,528 $117,000
Q1 2019 May 15, 2019	BUY	$0.67 - $1.01 $15,448 - $23,288	23,058 New	23,058 $0

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.85M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Castle Rock Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Castle Rock Wealth Management, LLC with notifications on news.